|
|
|
Volumn 12, Issue 3, 2004, Pages 83-88
|
|
Initiation of antiretroviral therapy: implications of recent findings.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CD4 LYMPHOCYTE COUNT;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG COMBINATION;
FEMALE;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HOSPITALIZATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MALE;
METHODOLOGY;
MORTALITY;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SURVIVAL;
TREATMENT OUTCOME;
VIRUS LOAD;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANTI-HIV AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CD4 LYMPHOCYTE COUNT;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
FEMALE;
HIV INFECTIONS;
HUMANS;
MALE;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS;
REVERSE TRANSCRIPTASE INHIBITORS;
SEVERITY OF ILLNESS INDEX;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
VIRAL LOAD;
|
|
EID: 5144226995
PISSN: 15428826
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (9)
|
|
References (15)
|
